LATEST UPDATES » Vol 22, No 04, April 2018 – Digestive health in the 21st century - Trust your guts       » Food wasted in China could feed 30-50 million       » Chinese scientists analyze human brain's "CPU"       » $150,000 fundraiser launched to sequence South Asian genomes       » Green tea-based drug carriers improve cancer treatment       » Scientists grow liver cancer cells in lab      
BIOBOARD For e-subscribers (PDF)
Vol 21, No 04, April 2017
NUS Study: Daily Consumption of Tea Protects the Elderly from Cognitive Decline

A cup of tea a day can keep dementia away, and this is especially so for those who are genetically predisposed to the debilitating disease, according to a recent study led by Assistant Professor Feng Lei from the Department of Psychological Medicine at National University of Singapore's (NUS) Yong Loo Lin School of Medicine. The longitudinal study involving 957 Chinese seniors aged 55 years or older has...

Singapore Researchers Use Patients' Stem Cells to Test for Side Effects of Drugs - Discovery Brings Doctors Closer to Personalized Medicine

Different people react differently to the same drug, yet it is difficult to predict the side effects for an individual in advance. Now, researchers from the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR and the National Cancer Centre Singapore (NCCS) have demonstrated a promising approach to screen for severe side effects by first testing the drug on stem cells made from the patient's blood...

Diabetes in Your DNA? Scientists Zero in on the Genetic Signature of Risk

ANN ARBOR, Mich. — Why do some people get Type 2 diabetes, while others who live the same lifestyle never do? For decades, scientists have tried to solve this mystery - and have found more than 80 tiny DNA differences that seem to raise the risk of the disease in some people, or protect others from the damagingly high levels of blood sugar that are its hallmark. But no one "Type 2 diabetes signature" has...

Super Resolution Imaging Helps Determine a Stem Cell's Future

Scientists at Rutgers and other universities have created a new way to identify the state and fate of stem cells earlier than previously possible. Understanding a stem cell's fate - the type of cell it will eventually become - and how far along it is in the process of development can help scientists better manipulate cells for stem cell therapy. The beauty of the method is its simplicity and versatility, said...

Wearable Biosensors Can Tell You When to See the Doctor

Your watch might be able to tell you it's time to call in sick. Researchers supported by the National Institutes of Health have revealed the ability of wearable biosensors, similar to the Apple Watch or Fitbit, to detect physiological changes that may indicate illness, even before symptoms appear. The findings, published Jan. 12, 2017, in PLoS Biology, may open the door to new ways to manage and monitor...

PromarkerD Predictive Diagnostics for DKD to Roll-out in Asia

PERTH, AUSTRALIA — Proteomics International Laboratories Ltd, a world leader in biomarker discovery in multiple project areas, was advancing deals in Singapore, Hong Kong and Shanghai for the Asia Pacific commercialization of PromarkerD, the ground-breaking test platform that uses protein biomarkers in the blood to predict the onset of diabetic kidney disease (DKD). Proteomics, or PILL, has been granted...

Enrollment Commences in Phase III Clinical Study of Eisai's BACE Inhibitor Elenbecestat in Early Alzheimer's Disease in Japan

TOKYO — Eisai Co., Ltd. announced on 29th Mar that enrollment has commenced in Japan for MISSION AD1, a global Phase III clinical study of the in-house developed oral beta secretase cleaving enzyme (BACE) inhibitor elenbecestat(1) (development code: E2609) in patients with early Alzheimer's disease (AD). The Phase III clinical trial program for elenbecestat (MISSION AD) consists of two global Phase III...

news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
Asia Pacific Biotech News
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
Obesity / Outlook for 2018
Searching for the fountain of youth
Women in Science - Making a difference
Digestive health in the 21st century - Trust your guts
Asthma / Dental health
Oncology / Biotech landscape in APAC
Water management / Vaccination
Regenerative medicine / Biotech start ups
Digital healthcare / 3D printing
Bones / Breast cancer
Liver health / Top science research nations & institutions
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy